Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Emmanuel Feroldi"'
Autor:
Anke Pagnon, Christophe Carre, Marion Aguirre, Emilie Chautard, Sophie Gimenez, Franck Raynal, Emmanuel Feroldi, Paul Scott, Kayvon Modjarrad, Manuel Vangelisti, Nathalie Mantel
Publikováno v:
EBioMedicine, Vol 108, Iss , Pp 105332- (2024)
Summary: Background: Yellow fever (YF), a mosquito-borne acute viral haemorrhagic illness, is endemic to many tropical and subtropical areas of Africa and Central and South America. Vaccination remains the most effective prevention strategy; however,
Externí odkaz:
https://doaj.org/article/2a2747ae42384d60b9b6678996455730
Autor:
Shabir A. Madhi, Pío López, Betzana Zambrano, Emilia Jordanov, Siham B’Chir, Fernando Noriega, Emmanuel Feroldi
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 3, Pp 658-668 (2019)
Objective: Antibody persistence evaluation for all antigens of a fully liquid DTaP-IPV-HB-PRP~T vaccine at 3.5 and 4.5 y of age following different primary series and booster schedules in South Africa and Latin America. Methods: Participants had comp
Externí odkaz:
https://doaj.org/article/72a4084b7ffa4c37a98eb077503572dd
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 1, Pp 72-79 (2019)
The live-attenuated Japanese encephalitis chimeric virus vaccine JE-CV (IMOJEV®, Sanofi Pasteur) elicits a robust antibody response in children, which wanes over time. Clinical efficacy is based on a correlate of protection against JE infection defi
Externí odkaz:
https://doaj.org/article/efa34ff6b2394eb6bf09f30d73313032
Autor:
Emmanuel Feroldi, Emilia Jordanov, Fernando Noriega, Betzana Zambrano, Pio Lopez, Siham B’Chir, Shabir A. Madhi
Publikováno v:
Human Vaccines & Immunotherapeutics
Objective: Antibody persistence evaluation for all antigens of a fully liquid DTaP-IPV-HB-PRP~T vaccine at 3.5 and 4.5 y of age following different primary series and booster schedules in South Africa and Latin America. Methods: Participants had comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9aca258faf2a29204237e79edf9cae10
https://doi.org/10.1080/21645515.2018.1546524
https://doi.org/10.1080/21645515.2018.1546524
Autor:
Laurent Fraisse, Marie-Helene Grillet, Yasemin Ataman-Önal, Tobias Manigold, Emmanuel Feroldi, Sébastien Laurent, David J. M. Lewis, Patrick Syntin, Benjamin Chousterman, Nicholas Jackson, Michel Doubovetzky, Nicolas Burdin, Ernesto Luna, Daniel Kramer, Nathalie Garçon
Publikováno v:
Vaccine. 38(51)
Vaccines prevent infectious diseases, but vaccination is not without risk and adverse events are reported although they are more commonly reported for biologicals than for vaccines. Vaccines and biologicals must undergo vigorous assessment before and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b867202d080cbd8e56148a89e6a21c6
https://pubmed.ncbi.nlm.nih.gov/33187767
https://pubmed.ncbi.nlm.nih.gov/33187767
Publikováno v:
Human Vaccines & Immunotherapeutics
The live-attenuated Japanese encephalitis chimeric virus vaccine JE-CV (IMOJEV®, Sanofi Pasteur) elicits a robust antibody response in children, which wanes over time. Clinical efficacy is based on a correlate of protection against JE infection defi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2bd194b4cfe58d7192dbeb14e281893
https://doi.org/10.1080/21645515.2018.1515455
https://doi.org/10.1080/21645515.2018.1515455
Autor:
Emmanuel Feroldi, Thelma Laot, Danaya Chansinghakul, Tifany Machabert, Céline Monfredo, Edison Alberto, Alain Bouckenooghe, Maria Rosario Capeding
Publikováno v:
The Journal of Infectious Diseases
This study shows that the immune response elicited by a Japanese encephalitis chimeric virus vaccine (JE-CV) booster in JE-CV–primed children in the Philippines induces long-lasting protection, and further supports the benefit of a booster irrespec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdbd751c2310edb165ce90f987ffe75d
https://doi.org/10.1093/infdis/jix601
https://doi.org/10.1093/infdis/jix601
Autor:
Mark Boaz, Emmanuel Feroldi, Chukiat Sirivichayakul, Alain Bouckenooghe, Kulkanya Chokephaibulkit, Chitsanu Pancharoen, Usa Thisyakorn
Publikováno v:
Vaccine. 34:5664-5669
A single dose of live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) was shown to be immunogenic and well tolerated when given either as a booster to formalin-inactivated Japanese encephalitis (JE)-vaccine (mouse brain-derived vaccin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6d2e5d88cc686f6ab022e86259e8eac
https://doi.org/10.1016/j.vaccine.2016.09.018
https://doi.org/10.1016/j.vaccine.2016.09.018
Publikováno v:
Expert Review of Vaccines. 15:153-166
JE-CV (IMOJEV®, Sanofi Pasteur, France) is a live attenuated virus vaccine constructed by inserting coding sequences of the prM and E structural proteins of the Japanese encephalitis SA14-14-2 virus into the genome of yellow fever 17D virus. Primary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea55443254893d2bb75b3cf0fa0de469
https://doi.org/10.1586/14760584.2016.1123097
https://doi.org/10.1586/14760584.2016.1123097
Autor:
Federico Martinón-Torres, Siham B’Chir, Javier Díez-Domingo, Emilia Jordanov, Xavier Da Costa, Emmanuel Feroldi
Publikováno v:
The Pediatric infectious disease journal. 38(3)
This study assessed a pediatric mixed hexavalent diphtheria (D)-tetanus (T)-acellular pertussis (aP)-inactivated poliovirus (IPV)-hepatitis B (HB)-Haemophilus influenzae b [polyribosylribitol phosphate (PRP-T)]-pentavalent (DTaP-IPV//PRP-T)-hexavalen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb68e332c0b9d36dd703c918bf28cd93
https://pubmed.ncbi.nlm.nih.gov/30408001
https://pubmed.ncbi.nlm.nih.gov/30408001